orphan drugs Orphan Drugs at 30: Will Success Become Too Expensive? By www.fdamatters.com Published On :: Mon, 14 Jan 2013 19:09:11 +0000 The Orphan Drug Act (ODA) turned 30 this month, demonstrating that good laws really can have an enduring impact. Amidst the celebrations, a reporter asked me a provocative question: can we afford more orphan drugs costing hundreds of thousands of dollars per year? FDA Matters answered “yes.” However, I added a caveat that should worry everyone eager for orphan drugs to succeed. When genomics and personalized medicine become successful, this will multiply the number of rare diseases and the overall cost of orphan drugs, perhaps beyond what the system can bear. Full Article FDA and Congress FDA and Industry Orphan Drugs
orphan drugs Understanding orphan drugs: what are they, how are they classified and what are their challenges in the Indian context By www.thehindu.com Published On :: Mon, 04 Nov 2024 12:28:54 +0530 While orphan drugs are crucial to treating rare, sometimes debilitating conditions, the high cost of their research and development is a major barrier to their development in India Full Article Health
orphan drugs COVID-19 leading to shortage of orphan drugs in Russia By www.thepharmaletter.com Published On :: Tue, 05 May 2020 10:09:00 +0100 The ongoing spread of COVID-19 in Russia is leading to shortages of drugs against orphan diseases in… Full Article Anti-virals/Coronavirus/Focus On/From our correspondent/Hydroxychloroquine/In Depth/Pharmaceutical/Public health/Rare diseases/Russia/Russian market
orphan drugs Expert opinion on orphan drugs [electronic journal]. By encore.st-andrews.ac.uk Published On :: London : Informa Healthcare Full Article
